Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
Gnant M; Baselga J; Rugo HS; Noguchi S; Burris HA; Piccart M; Hortobagyi GN; Eakle J; Mukai H; Iwata H; Geberth M; Hart LL; Hadji P; El-Hashimy M; Rao S; Taran T; Sahmoud T; Lebwohl D; Campone M; Pritchard KI; Journal Of The National Cancer Institute, 2013, vol. 105, issue 9, p 654, ISSN 14602105. ISBN 14602105.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef